The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Association of Activated Vitamin D Treatment and Mortality in Chronic Kidney Disease
Open accessAbstract
BACKGROUND: Treatment of secondary hyperparathyroidism (SHPT) with activated vitamin D analogues is associated with better survival in patients receiving dialysis. It is unclear whether such a benefit is present in patients with predialysis chronic kidney disease (CKD). METHODS: We examined the association of oral calcitriol treatment with mortality and the incidence of dialysis in 520 male US veterans (mean [SD] age, 69.8 [10.3] years; 23.5% black) with CKD stages 3 to 5 and not yet receiving dialysis (mean [SD] estimated glomerular filtration rate, 30.8 [11.3]). Associations were examined by the Kaplan-Meier method and in Poisson regression models with adjustment for age, race, comorbidities, smoking, blood pressure, body mass index, use of phosphate binders, estimated glomerular filtration rate, proteinuria, white blood cell count, percentage of lymphocytes, and levels of parathyroid hormone, calcium, phosphorus, albumin, bicarbonate, and hemoglobin. RESULTS: Two hundred fifty-eight of 520 subjects received treatment with calcitriol, 0.25 to 0.5 microg/d, for a median duration of 2.1 years (range, 0.06-6.0 years). The incidence rate ratios for mortality and combined death and dialysis initiation were significantly lower in treated vs untreated patients (P < .001 for both in the fully adjusted models). Treatment with calcitriol was associated with a trend toward a lower incidence of dialysis. These results were consistent across different subgroups. CONCLUSIONS: Treatment with the activated vitamin D analogue calcitriol appears to be associated with significantly greater survival in patients with CKD not yet receiving dialysis. Randomized clinical trials are required to verify the causality of these associations and to examine whether similar associations are seen with different activated vitamin D analogues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Levin, A., Bakris, G. L., Molitch, M., Smulders, M., Tian, J., Williams, L. A., & Andress, D. L. (2007) · Kidney International · doi:10.1038/sj.ki.5002009 · Cited by 1,513
Bone metabolism and disease in chronic kidney disease
Eknoyan, G., Levin, A., & Levin, N. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00905-3 · Cited by 1,286
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M., & O'Garra, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011629 · Cited by 1,161
Boonstra, A., Barrat, F. J., Crain, C., Heath, V. L., Savelkoul, H. F. J., & O’Garra, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.4974 · Cited by 1,123
Interpretation of Serum Calcium in Patients with Abnormal Serum Proteins
Payne, R. B., Little, A. J., Williams, R. B., & Milner, J. R. (1973) · BMJ · doi:10.1136/bmj.4.5893.643 · Cited by 945
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
Teng, M., Wolf, M., Lowrie, E., Ofsthun, N., Lazarus, J. M., & Thadhani, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022536 · Cited by 927
Kalantar-Zadeh, K., Kuwae, N., Regidor, D. L., Kovesdy, C. P., Kilpatrick, R. D., Shinaberger, C. S., McAllister, C. J., Budoff, M. J., Salusky, I. B., & Kopple, J. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001514 · Cited by 905
Self-citationVitamin D levels and early mortality among incident hemodialysis patients
Wolf, M., Shah, A., Gutierrez, O., Ankers, E., Monroy, M., Tamez, H., Steele, D., Chang, Y., Camargo, C. A., Tonelli, M., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002451 · Cited by 789
Activated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study
Teng, M., Wolf, M., Ofsthun, M. N., Lazarus, J. M., Hernán, M. A., Camargo, C. A., & Thadhani, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070573 · Cited by 782
The spectrum of bone disease in end-stage renal failure—An evolving disorder
Sherrard, D. J., Hercz, G., Pei, Y., Maloney, N. A., Greenwood, C., Manuel, A., Saiphoo, C., Fenton, S. S., & Segre, G. V. (1993) · Kidney International · doi:10.1038/ki.1993.64 · Cited by 730
Active Serum Vitamin D Levels Are Inversely Correlated With Coronary Calcification
Watson, K. E., Abrolat, M. L., Malone, L. L., Hoeg, J. M., Doherty, T., Detrano, R., & Demer, L. L. (1997) · Circulation · doi:10.1161/01.cir.96.6.1755 · Cited by 482
Mortality risk among hemodialysis patients receiving different vitamin D analogs
Tentori, F., for the Medical Directors of Dialysis Clinic Inc., Hunt, W. C., Stidley, C. A., Rohrscheib, M. R., Bedrick, E. J., Meyer, K. B., Johnson, H. K., & Zager, P. G. (2006) · Kidney International · doi:10.1038/sj.ki.5001868 · Cited by 391
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
Agarwal, R., Acharya, M., Tian, J., Hippensteel, R. L., Melnick, J. Z., Qiu, P., Williams, L., & Batlle, D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00755.x · Cited by 377
Rix, M., Andreassen, H., Eskildsen, P., Langdahl, B., & Olgaard, K. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00617.x · Cited by 309
Inter-method variability in PTH measurement: Implication for the care of CKD patients
Souberbielle, J.-C., Boutten, A., Carlier, M.-C., Chevenne, D., Coumaros, G., Lawson-Body, E., Massart, C., Monge, M., Myara, J., Parent, X., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001606 · Cited by 290
Disruption of Nuclear Vitamin D Receptor Gene Causes Enhanced Thrombogenicity in Mice
Aihara, K.-I., Azuma, H., Akaike, M., Ikeda, Y., Yamashita, M., Sudo, T., Hayashi, H., Yamada, Y., Endoh, F., Fujimura, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404865200 · Cited by 268
Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease
Schwarz, S., Trivedi, B. K., Kalantar-Zadeh, K., & Kovesdy, C. P. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02101205 · Cited by 263
Self-citationStaeva-Vieira, T. P., & Freedman, L. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1181 · Cited by 263
Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD
Coyne, D., Acharya, M., Qiu, P., Abboud, H., Batlle, D., Rosansky, S., Fadem, S., Levine, B., Williams, L., Andress, D. L., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.007 · Cited by 227
de Boer, I. H., Gorodetskaya, I., Young, B., Hsu, C.-Y., & Chertow, G. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034202.91413.eb · Cited by 181
Coburn, J. W., Maung, H. M., Elangovan, L., Germain, M. J., Lindberg, J. S., Sprague, S. M., Williams, M. E., & Bishop, C. W. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.01.012 · Cited by 174
1,25-(OH)2-Vitamin D3 Suppresses the Bone-Related Runx2/Cbfa1 Gene Promoter
Drissi, H. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5474 · Cited by 173
Fraser, J. D., Otawara, Y., & Price, P. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)35439-0 · Cited by 142
Relationship of Phosphorus and Calcium-Phosphorus Product With Mortality in CKD
Menon, V., Greene, T., Pereira, A. A., Wang, X., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Sarnak, M. J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.025 · Cited by 126
Bellows, C. G., Reimers, S., & Heersche, J. N. M. (1999) · Cell and Tissue Research · doi:10.1007/s004410051353 · Cited by 115
Kovesdy, C. P., Trivedi, B. K., Kalantar‐Zadeh, K., & Anderson, J. E. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk057 · Cited by 115
Self-citationCalcitriol modulates in vivo and in vitro cytokine production: A role for intracellular calcium
Panichi, V., Pietro, S. D., Andreini, B., Bianchi, A. M., MIGLIORI, M., Taccola, D., Giovannini, L., Tetta, C., & Palla, R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00152.x · Cited by 88
Przedlacki, J., Manelius, J., & Huttunen, K. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188515 · Cited by 59
Neurologic complications of thyroid and parathyroid disease
Tonner, D., & Schlechte, J. (1993) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30282-6 · Cited by 52
Virdi, A. S., Cook, L., Oreffo, R. O. C., & Triffitt, J. T. (1998) · PubMed · Cited by 50
Cited by
Herzog, C. A., Asinger, R. W., Berger, A. K., Charytan, D. M., Díez, J., Hart, R. G., Eckardt, K.-U., Kasiske, B. L., McCullough, P. A., Passman, R. S., et al. (2011) · Kidney International · doi:10.1038/ki.2011.223 · Cited by 922
Lee, J. H., O'Keefe, J. H., Bell, D., Hensrud, D. D., & Holick, M. F. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.050 · Cited by 724
Pilz, S., März, W., Wellnitz, B., Seelhorst, U., Fahrleitner-Pammer, A., Dimai, H. P., Boehm, B. O., & Dobnig, H. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0784 · Cited by 607
Vitamin D levels and patient outcome in chronic kidney disease
Ravani, P., Malberti, F., Tripepi, G., Pecchini, P., Cutrupi, S., Pizzini, P., Mallamaci, F., & Zoccali, C. (2009) · Kidney International · doi:10.1038/ki.2008.501 · Cited by 437
Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Metadata
- Authors
- Kovesdy, C. P.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2008-02-25
- Volume
- 168
- Issue
- 4
- Pages
- 397
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2009949027
- Cited by
- 277
- References
- 35
- FWCI
- 33.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.